Detection of Human Cytomegalovirus lncRNA4.9 in Breast Tumor Tissue Using RNA In Situ Hybridization
Journal of Histochemistry & Cytochemistry · 2026-12 · 74 (6) · 687-705
DOI: 10.1369/00221554261474562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Histochemistry & Cytochemistry, online erschienen am 19.08.2026. Verfasst von Arthur Morley-Bunker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Molecular Medicine, University of Otago, Christchurch, Christchurch, New Zealand. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Cytomegalovirus, Breast Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Society of New Zealand.
Abstract (Originalsprache)
Human cytomegalovirus (HCMV) has been linked to tumor progression in several cancers, but its role in breast cancer remains uncertain. This study investigated HCMV long non-coding RNA4.9 ( lncRNA4.9 ) in three breast cancer subtypes (ER+/PR+, n =25; HER2-positive n =24; triple-negative, n =26) and normal breast tissue ( n =5) using RNAscope. Serum HCMV IgG and IgM levels were measured, and immunohistochemistry was used to assess the pan-macrophage marker CD68 in breast tissue. HCMV IgG seropositivity was more common in ER+ patients, while IgM positivity was more frequent in HER2-positive and triple-negative cases. HCMV lncRNA4.9 signals were detected in over half of tumor samples, localizing to invasive tumor cells, stromal cells, adipose tissue, and ductal carcinoma in situ (DCIS). Although detection rates did not differ significantly between breast cancer subtypes, triple-negative tumors exhibited mid- to high-level lncRNA4.9 expression. Immunohistochemical analysis demonstrated CD68+ cells present in most tumors and were more abundant in HCMV lncRNA4.9 -positive samples. These cells co-localized with lncRNA4.9 -positive cells at invasive margins, while in associated foci of DCIS, CD68+ cells were present in surrounding stroma. This study provides the first demonstration of HCMV lncRNA4.9 in breast tissue and supports HCMV’s potential role in the biology of a subset of breast cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Molecular Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
- Anatomical Pathology, Canterbury Health Laboratories, Te Whatu Ora-Health New Zealand Waitaha Canterbury, Christchurch, New Zealand.
- He Taonga Tapu Cancer Society Tissue Bank, Christchurch, Aotearoa New Zealand.
- Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
ORCID-Profile: Arthur Morley-Bunker, Georgia Turner, John Pearson, Margaret Currie
Förderung
- Cancer Society of New Zealand
Zitieren
APA
Morley-Bunker, A., Turner, G., Beardsley, B., Morrin, H., Pearson, J., Walker, L. C., & Currie, M. (2026). Detection of Human Cytomegalovirus lncRNA4.9 in Breast Tumor Tissue Using RNA In Situ Hybridization. Journal of Histochemistry & Cytochemistry, 74(6), 687-705. https://doi.org/10.1369/00221554261474562
Vancouver
Morley-Bunker A, Turner G, Beardsley B, Morrin H, Pearson J, Walker LC, et al. Detection of Human Cytomegalovirus lncRNA4.9 in Breast Tumor Tissue Using RNA In Situ Hybridization. Journal of Histochemistry & Cytochemistry. 2026;74(6):687-705. doi:10.1369/00221554261474562
BibTeX
@article{MorleyBunker2026,
author = {Morley-Bunker, Arthur and Turner, Georgia and Beardsley, Brooke and Morrin, Helen and Pearson, John and Walker, Logan C and Currie, Margaret},
title = {Detection of Human Cytomegalovirus lncRNA4.9 in Breast Tumor Tissue Using RNA In Situ Hybridization},
journal = {Journal of Histochemistry & Cytochemistry},
year = {2026},
volume = {74},
number = {6},
pages = {687--705},
doi = {10.1369/00221554261474562}
}
EUVIMED